EVOTAZ
Total Payments
$25,507
Transactions
217
Doctors
133
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $61.65 | 3 | 3 |
| 2019 | $12.74 | 1 | 1 |
| 2017 | $25,433 | 213 | 129 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,928 | 6 | 46.8% |
| Consulting Fee | $6,500 | 13 | 25.5% |
| Food and Beverage | $5,972 | 187 | 23.4% |
| Travel and Lodging | $1,107 | 11 | 4.3% |
Top Doctors Receiving Payments for EVOTAZ — Page 6
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , DO | Infectious Disease | Southfield, MI | $11.61 | 1 |
| , MD | Hematology & Oncology | Southfield, MI | $11.61 | 1 |
| , MD | Internal Medicine | Athens, GA | $11.61 | 1 |
| , MD | Family Medicine | Columbia, MD | $11.49 | 1 |
| , MD | Child & Adolescent Psychiatry | Baltimore, MD | $11.49 | 1 |
| , MD | Infectious Disease | Baltimore, MD | $11.49 | 1 |
| , MD | Family Medicine | Fort Pierce, FL | $11.16 | 1 |
| , DO | Hematology | Ormond Beach, FL | $10.50 | 1 |
Ad
Manufacturing Companies
- E.R. Squibb & Sons, L.L.C. $25,507
Product Information
- Type Drug
- Total Payments $25,507
- Total Doctors 133
- Transactions 217
About EVOTAZ
EVOTAZ is a drug associated with $25,507 in payments to 133 healthcare providers, recorded across 217 transactions in the CMS Open Payments database. The primary manufacturer is E.R. Squibb & Sons, L.L.C..
Payment data is available from 2017 to 2022. In 2022, $61.65 was paid across 3 transactions to 3 doctors.
The most common payment nature for EVOTAZ is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,928, 46.8% of total).